Will Tesla Stock Go Up In 2026?
EV giant Tesla (NASDAQ:TSLA) has, somewhat surprisingly, undershot the broader…
Sell
37
PEPG Quote, Financials, Valuation and Earnings
Last price:
$5.51
Seasonality move
:
57.46%
Day range:
$5.35 - $5.69
52-week range:
$0.88 - $6.72
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.31x
Volume:
318.3K
Avg. volume:
718.3K
1-year change:
22.39%
Market cap:
$376.1M
Revenue:
--
EPS (TTM):
-$2.84
Analysts' Opinion
-
Consensus RatingPepGen Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $10.00, PepGen Inc. has an estimated upside of 82.82% from its current price of $5.52.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $3.00 representing 100% downside risk from its current price of $5.52.
Fair Value
-
According to the consensus of 5 analysts, PepGen Inc. has 82.82% upside to fair value with a price target of $10.00 per share.
PEPG vs. S&P 500
-
Over the past 5 trading days, PepGen Inc. has underperformed the S&P 500 by -1.14% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
PepGen Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
PepGen Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter PepGen Inc. reported revenues of --.
Earnings Growth
-
PepGen Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter PepGen Inc. reported earnings per share of -$0.52.
Enterprise value:
229.8M
EV / Invested capital:
1.27x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-2.68x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$1.4M
Return On Assets:
-63.15%
Net Income Margin (TTM):
--
Return On Equity:
-80.35%
Return On Invested Capital:
-69.46%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$975K | -$1.5M | -$1.4M | -$379K | -$339K | |
| Operating Income | -$81.2M | -$94.2M | -$98.3M | -$23.2M | -$18.7M | |
| EBITDA | -$80.2M | -$92.7M | -$96.8M | -$22.8M | -$18.3M | |
| Diluted EPS | -$3.12 | -$2.98 | -$2.84 | -$0.66 | -$0.52 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $147M | $204.2M | $133.1M | $142.4M | $166.2M | |
| Total Assets | $149M | $208.5M | $164.3M | $170.2M | $190.1M | |
| Current Liabilities | $9.2M | $15.5M | $21M | $16.8M | $12.6M | |
| Total Liabilities | $9.5M | $15.5M | $38.4M | $32.8M | $26.9M | |
| Total Equity | $139.6M | $192.9M | $125.9M | $137.5M | $163.1M | |
| Total Debt | -- | -- | $17.5M | $16M | $14.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$63M | -$82.3M | -$85.3M | -$24M | -$19.3M | |
| Cash From Investing | -$3.5M | -$93.8M | $77.5M | -$133K | $18.9M | |
| Cash From Financing | $2K | $88.6M | $108.3M | $327K | $108.1M | |
| Free Cash Flow | -$66.5M | -$82.8M | -$85.8M | -$24.2M | -$19.4M | |
PEPG
Sector
Market Cap
$376.1M
$28M
Price % of 52-Week High
81.4%
51.86%
Dividend Yield
0%
0%
Shareholder Yield
-33.97%
-1.4%
1-Year Price Total Return
16.88%
-19%
Beta (5-Year)
--
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$5.62
200-day SMA
Buy
Level
$2.53
Bollinger Bands (100)
Buy
Level
1.69 - 5.41
Chaikin Money Flow
Sell
Level
-14.1M
20-day SMA
Sell
Level
$5.64
Relative Strength Index (RSI14)
Buy
Level
52.37
ADX Line
Sell
Level
14.96
Williams %R
Neutral
Level
-73.9645
50-day SMA
Buy
Level
$5.10
MACD (12, 26)
Buy
Level
0.18
25-day Aroon Oscillator
Buy
Level
52
On Balance Volume
Neutral
Level
299.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-1.5059)
Sell
CA Score
(Annual)
Level (-2.2132)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (5.141)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.
Stock Forecast FAQ
In the current month, PEPG has received 5 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PEPG average analyst price target in the past 3 months is $10.00.
-
Where Will PepGen Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that PepGen Inc. share price will rise to $10.00 per share over the next 12 months.
-
What Do Analysts Say About PepGen Inc.?
Analysts are divided on their view about PepGen Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that PepGen Inc. is a Sell and believe this share price will drop from its current level to $3.00.
-
What Is PepGen Inc.'s Price Target?
The price target for PepGen Inc. over the next 1-year time period is forecast to be $10.00 according to 5 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is PEPG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for PepGen Inc. is a Buy. 5 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of PEPG?
You can purchase shares of PepGen Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase PepGen Inc. shares.
-
What Is The PepGen Inc. Share Price Today?
PepGen Inc. was last trading at $5.51 per share. This represents the most recent stock quote for PepGen Inc.. Yesterday, PepGen Inc. closed at $5.52 per share.
-
How To Buy PepGen Inc. Stock Online?
In order to purchase PepGen Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get PEPG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PEPG
Sector
P/E ratio
--
24.31x
PEG ratio
--
-0.01x
P/B ratio
2.31x
1.83x
Price / LTM sales
--
1.60x
Growth Metrics
PEPG
Sector
Revenue growth
--
4.6%
Earnings growth
20.07%
10.88%
Revenue (5-year growth)
--
6.5%
Earnings forecast
-$0.57
-$0.20
Profitability
PEPG
Sector
Profitability FY 2024
-$1.5M
$3.5M
Return on invested capital
-69.46%
-31.66%
Return on assets
-63.15%
-27.84%
Return on equity
-80.35%
-37.28%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Mar
2
Estimated Next Earnings Date
Feb
11
Balance Sheet
PEPG
Sector
Total cash
$163.7M
$26.8M
Short term investments
$70.8M
$26M
Total assets
$150.9M
$78.7M
Long term debt
$14.3M
$3.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Are the Best AI Power Stocks?
As the construction of AI infrastructure accelerates, the gap between…
Is IONQ The Best Quantum Stock to Buy?
Riding a wave of investor enthusiasm for the technology, quantum…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 60x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
71
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
39
SMX alert for Dec 17
SMX (Security Matters) Plc [SMX] is down 18.2% over the past day.
Sell
33
ZBIO alert for Dec 17
Zenas BioPharma, Inc. [ZBIO] is up 13.35% over the past day.
Buy
75
AFRM alert for Dec 17
Affirm Holdings, Inc. [AFRM] is up 11.77% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
